Exane Derivatives’s Enbridge ENB Stock Holding History
Bought
Maintained
Sold
Other funds holding ENB
Exane Derivatives's ENB Position: Q2 2022 in Review
Exane Derivatives reduced its Enbridge (ENB) stake by 100% in Q2 2022, selling an estimated $314K and leaving 1 share worth $42. The position accounts for ﹤0.01% of the portfolio, ranked #744.
Exane Derivatives first reported a position in ENB in Q4 2014 and has held it in 31 quarters since. The position peaked at $426K in Q4 2019. 1,224 funds tracked by Wall St. Rank hold ENB as of Q2 2022.
- Exane Derivatives held 1 share of Enbridge worth $42 as of Q2 2022.
- Exane Derivatives sold 7,033 Enbridge shares in Q2 2022, an estimated $314K.
- Enbridge made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #744 holding.
- Exane Derivatives first reported a position in Enbridge in Q4 2014 and has held it in 31 quarters since.
- Exane Derivatives's Enbridge position peaked at $426K in Q4 2019.
- 1,224 funds tracked by Wall St. Rank held Enbridge as of Q2 2022.
Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.